Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease

N/ACompletedNCT01819714

Centre Hospitalier Universitaire de Nīmes31 enrolled

Overview

The main objective of this study is to evaluate the effect of 3 months of "Snoezelen-type" multi-sensory care sessions on NeuroPsychiatric Inventory Questionnaire (NPI-Q) scores for patients with Alzheimer's-type neurodegenerative disease.

The secondary objectives of this study are to study the following elements in relationship to the implementation of a "Snoezelen-type" multi-sensory care strategy for patients with Alzheimer's-type neurodegenerative disease: A. to evaluate the effects on NPI-Q scores at 1 month, 6 months and 12 months . B. evaluate the effects on quality of life (questionnaire QOL-AD) at 0 and 12 months. C. assess changes in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire over 0, 1, 3, 6 and 12 months. D. assess changes in drug consumption (anxiolytics, antidepressants, hypnotics, neuroleptics)over the study period

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Alzheimer Disease

Interventions

Multi-sensory supportive careOTHER

The Serre-Cavalier center will implement Snoezelen-type multisensory care sessions for included patients; these care sessions correspond with the patients' daily hygiene/toilette care. The impact of this multisensory strategy will be evaluated using a before-after design.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The patient's legal representative must have given his/her informed and signed consent (or the patient if he/she is judged competent) * The patient must be insured or beneficiary of a health insurance plan * Alzheimer's-type neurodegenerative pathology * The patient has been living in the participating center for \> 2 months Exclusion Criteria: * The patient's legal representative refuses to sign the consent (or the patient if he/she is judged competent) * It is impossible to correctly inform the patient's legal representative * The patient has already has Snoezelen-therapy

Locations (1)

CHU de Nîmes - Centre de Gérontologie de Serre Cavalier

Nîmes, France

Outcomes

Primary Outcomes

Change from baseline in NPI-Q scores

Time frame: 3 months

Secondary Outcomes

Change from baseline in NPI-Q scores

Time frame: 1 month

Change from baseline in NPI-Q scores

Time frame: 6 months

Change from baseline in NPI-Q scores

Time frame: 12 months

Change from baseline in the Quality-of-life-Alzheimer's Disease questionnaire (QOL-AD)

Time frame: 12 months

Change from baseline in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire

Time frame: 1 month

Change from baseline in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire

Time frame: 3 months

Change from baseline in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire

Time frame: 6 months

Change from baseline in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire

Time frame: 12 months

Change in drug consumption from baseline

Time frame: 1 month

Change in drug consumption from baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.